YESTAR HEALTH (02393): Non-executive director He Zhenfa's holdings of approximately 268 million shares of the company have been taken over.

YESTAR HEALTH (02393) announced that on January 21, 2025, the Board of Directors received a letter from Mr. Huo Xiyu and Mr. Zhou Weicheng of FTI Consulting (the joint and separate receivers, who have been appointed as receivers of approximately 2.68 billion shares of the company's common stock held by Mr. He Zhenfa, a non-executive director of the company). The pledged shares account for approximately 11.49% of the total number of shares issued by the company as of the date of this announcement. The announcement stated that the company's current business and operations are proceeding as usual. The Board of Directors hereby reiterates that the receivership does not involve the company itself or its assets.